China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.564
-0.024 (-4.13%)
At close: Apr 28, 2026, 4:00 PM EDT
0.500
-0.064 (-11.35%)
Pre-market: Apr 29, 2026, 5:15 AM EDT
China Pharma Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 4.14 | 4.53 | 7.01 | 8.1 | 9.64 | |
| Revenue Growth (YoY) | -8.49% | -35.41% | -13.48% | -15.95% | -11.27% | |
| Cost of Revenue | 4.28 | 6.51 | 7.29 | 8.6 | 9.29 | |
| Gross Profit | -0.13 | -1.99 | -0.28 | -0.49 | 0.35 | |
| Selling, General & Admin | 2.83 | 2.31 | 2.25 | 2.96 | 3.15 | |
| Research & Development | 0.13 | 0.28 | 0.24 | 0.19 | 0.32 | |
| Operating Expenses | 2.96 | 2.6 | 2.47 | 3.06 | 3.21 | |
| Operating Income | -3.09 | -4.59 | -2.75 | -3.55 | -2.86 | |
| Interest Expense | -0.1 | -0.15 | -0.33 | -0.43 | -0.54 | |
| Interest & Investment Income | 0 | 0.01 | 0.01 | 0.01 | 0 | |
| EBT Excluding Unusual Items | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | |
| Pretax Income | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | |
| Net Income | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | |
| Net Income to Common | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | |
| Shares Outstanding (Basic) | 4 | 2 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 4 | 2 | 0 | 0 | 0 | |
| Shares Change (YoY) | 145.73% | 416.13% | 221.82% | 13.96% | 5.75% | |
| EPS (Basic) | -0.74 | -2.71 | -9.10 | -37.79 | -36.85 | |
| EPS (Diluted) | -0.74 | -2.71 | -9.10 | -37.79 | -36.85 | |
| Free Cash Flow | 0.09 | -0.44 | -0.71 | -0.81 | -0.69 | |
| Free Cash Flow Per Share | 0.02 | -0.26 | -2.10 | -7.72 | -7.46 | |
| Gross Margin | -3.18% | -43.84% | -4.01% | -6.09% | 3.62% | |
| Operating Margin | -74.50% | -101.32% | -39.25% | -43.79% | -29.67% | |
| Profit Margin | -76.92% | -104.58% | -43.91% | -49.02% | -35.26% | |
| Free Cash Flow Margin | 2.15% | -9.81% | -10.14% | -10.01% | -7.13% | |
| EBITDA | -1.58 | -1.97 | 0 | -0.85 | 0.23 | |
| EBITDA Margin | -38.22% | -43.52% | 0.03% | -10.47% | 2.36% | |
| D&A For EBITDA | 1.5 | 2.62 | 2.75 | 2.7 | 3.09 | |
| EBIT | -3.09 | -4.59 | -2.75 | -3.55 | -2.86 | |
| EBIT Margin | -74.50% | -101.32% | -39.25% | -43.79% | -29.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.